The CD47/SIRPα axis was defined as an innate immune checkpoint in several tumor models, which stimulates antigen-presenting cell function and consequently the adaptive T cell-mediated anti-tumor immunity [44,45]. This evidence concerns the gene SIRPA and neoplasm.